Loading...
NPI 1205833662 · La Palma, CA · Rheumatology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Gerald Ho is a rheumatology physician provider located in La Palma, California. This profile covers 56 Medicare and 14 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Gerald Ho |
| Address | 5451 La Palma Ave |
| City | La Palma |
| State | CA |
| ZIP | 90623 |
| Taxonomy | Rheumatology Physician |
| NPI Enumerated | June 30, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.5M |
| Medicaid | $745.5K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
56 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 24,180 | $20 | $362.6K |
| J0897 | Injection, denosumab, 1 mg | 18,120 | $20 | $326.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 3,100 | $100 | $300.2K |
| J3262 | Injection, tocilizumab, 1 mg | 94,930 | $1 | $284.8K |
| J0490 | Injection, belimumab, 10 mg | 14,740 | $10 | $176.9K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 26,600 | $10 | $159.6K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 10,410 | $10 | $135.3K |
| Q5115 | Injection, rituximab-abbs, biosimilar, (truxima), 10 mg | 4,300 | $30 | $111.8K |
| J7332 | Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg | 13,220 | $10 | $105.8K |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 3,830 | $30 | $99.6K |
Showing 1–10 of 56
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 56 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
56 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J9312 | 10 | 20 | 4,370 | $60 | $382.1K |
| J0129 | 8 | 80 | 6,610 | $30 | $305.3K |
| J3262 | 4 | 50 | 29,000 | $1 | $203.8K |
| J0490 | 1 | 10 | 5,140 | $30 | $182.8K |
| J1602 | 10 | 70 | 11,550 | $10 | $167.1K |
| Q5115 | 1 | 10 | 3,500 | $30 | $111.7K |
| J1745 | 4 | 70 | 2,350 | $30 | $96.5K |
| J0897 | 39 | 1,030 | 3,060 | $20 | $91.4K |
| Q5104 | 2 | 10 | 1,900 | $30 | $62.4K |
| J7332 | 1 | 30 | 2,420 | $10 | $28.6K |
Showing 1–10 of 56
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
14 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 8,380 | $50 | $452.4K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 900 | $100 | $87K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 910 | $90 | $79.6K |
| 73120 | X–rays of the extremities have been performed to assess injury, fracture, arthritis, bone spurs, tumors, or congenital abnormalities. Extremity X–rays include the hand, wrist, arm, foot, ankle, hip,… | 1,690 | $20 | $33.7K |
| 73620 | In this diagnostic procedure, the provider takes two X–ray views of a patient’s foot to assess an injury, fracture, arthritis, tumor, or congenital abnormality. | 1,590 | $20 | $30.2K |
| 96366 | The provider administers an intravenous infusion or infusions of a medication for an additional hour or subsequent hours after the first hour to prevent, treat, or diagnose a condition or disease. | 400 | $60 | $24.3K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 460 | $30 | $14.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 330 | $40 | $12K |
| 73560 | In this procedure, the provider takes one or two X–ray images of a patient’s knee joint to check for any fracture, swelling, or reason for pain in the knee area. | 270 | $20 | $5.7K |
| 20611 | In this procedure, the provider inserts a needle through the skin of a patient and into a major joint or bursa, typically the shoulder, hip, knee, or subacromial bursa, and then uses the syringe… | 100 | $20 | $2.2K |
Showing 1–10 of 14
How this provider's Medicaid billing volume and revenue compare to other California providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. California median
14 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 374 | 500 | 3,580 | $40 | $230.4K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 309 | 520 | 1,470 | $70 | $193.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,527 | 13,300 | 640 | $40 | $169.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 9,118 | 14,520 | 760 | $10 | $122.8K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 1,329 | 5,870 | 180 | $70 | $73K |
| 96372 | A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician… | 1,803 | 2,380 | 350 | $20 | $50.3K |
| 96366 | The provider administers an intravenous infusion or infusions of a medication for an additional hour or subsequent hours after the first hour to prevent, treat, or diagnose a condition or disease. | 174 | 310 | 540 | $40 | $48K |
| 20611 | In this procedure, the provider inserts a needle through the skin of a patient and into a major joint or bursa, typically the shoulder, hip, knee, or subacromial bursa, and then uses the syringe… | 106 | 160 | 240 | $40 | $45.1K |
| 72100 | The technician takes 2 or 3 views of the vertebrae in the lumbar region which is the lower part of the spine and the sacrum, the area that connects the spine to the pelvis. Lumbosacral spine X–rays… | 567 | 750 | 300 | $20 | $27.2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 649 | 820 | 510 | $10 | $18.4K |
Showing 1–10 of 14
Other providers in the same ZIP code as Gerald Ho, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Sang Kim | CA | Foot & Ankle Surgery Podiatrist | $236.8K | $10.7K |
| Sharon Hatae-vargas | CA | Occupational Therapist | $231.2K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.